Executive Summary
Strong market need and timing, but requires validation of AI accuracy and user trust in medical contexts.
One-Line Summary
Clinical Trial Navigator is a mobile-first platform that uses AI to translate complex clinical trial eligibility criteria into plain language, helping patients with chronic conditions discover, understand, and track relevant trials they might otherwise miss.
Core Problem Solved
Patients with serious conditions face overwhelming barriers to clinical trial participation. With 450,000+ trials on ClinicalTrials.gov written in impenetrable medical jargon, patients waste weeks researching options that may be irrelevant. The average trial runs 6 months behind schedule due to recruitment challenges, while patients miss potentially life-saving opportunities.
Current solutions are either too technical (government databases) or pharma-focused without patient-centric design. The cost of inaction is measured in delayed treatments, progression of disease, and lost research opportunities that could benefit future patients.
Primary Audience
Adults aged 35-75 with chronic or serious conditions (cancer, rare diseases, autoimmune disorders) actively seeking alternatives to standard care. They're digitally literate, health-engaged, and often supported by caregivers who conduct research on their behalf. This audience values transparency, clear communication, and time efficiency during stressful health journeys.
Market Size Breakdown
TAM: $2.1B (global clinical trial recruitment market)
SAM: $850M (US patient-facing recruitment tools and services)
SOM: $25M (2.9% SAM capture in 3 years through direct-to-patient + hospital partnerships)
Market Timing ("Why Now?")
Three converging trends create perfect timing: (1) FDA's push for patient-centric trial design, (2) maturation of LLMs capable of accurately parsing medical text, and (3) increased patient empowerment post-pandemic. Clinical trial recruitment remains the industry's biggest bottleneck, with pharma companies actively seeking ethical patient recruitment solutions.
The competitive landscape shows gaps: government databases lack UX, while existing startups focus primarily on B2B rather than patient experience. Regulatory tailwinds support patient access to trial information.
Competitive Positioning Matrix
High Complexity
Free
High Complexity
Premium
Medium Complexity
Premium
Navigator
Low Complexity
Freemium
Our positioning in the low-complexity, freemium quadrant addresses the critical patient experience gap that competitors overlook.
Financial Snapshot
- Estimated MVP Development Cost: $120K-$180K (leveraging AI APIs and existing clinical data sources)
- Revenue Model: Freemium SaaS ($9.99/month) + B2B lead fees from pharma/hospitals
- Break-Even Timeline: 18 months (assuming 8,000 MAU with 3% premium conversion)
- Unit Economics Preview: Target LTV:CAC ratio of 4:1
Top 3 Highlights
Proprietary approach to converting complex eligibility criteria into plain language with explainable match scores. This solves the fundamental comprehension barrier that prevents patient participation.
Combines direct-to-patient subscriptions with B2B partnerships, creating multiple paths to sustainability. Pharma companies spend $2B annually on recruitment and are actively seeking ethical solutions.
FDA's patient-centric trial initiatives, combined with mature AI capabilities and post-pandemic health engagement, create ideal conditions for adoption. The recruitment bottleneck affects every major pharma company.
Overall Viability Scores
Average Score: 7.2/10 – Strong fundamentals with execution risks requiring validation.
Critical Success Factors
- Achieve >90% accuracy in AI eligibility parsing through clinical validation
- Build trust with clear medical disclaimers and physician collaboration
- Secure pilot partnerships with 2-3 hospital systems for distribution
- Maintain sub-$15 CAC through organic health community channels
Key Risks & Mitigations
Mitigation: Implement clear disclaimers, require physician consultation, and engage clinical advisors for content review
Mitigation: Use retrieval-augmented generation with source citations and implement user feedback loops for continuous improvement
Mitigation: Build notification system for new trials and status changes to drive recurring engagement
Success Metrics (First 6 Months)
- Monthly Active Users: 3,000+ (indicates sustained engagement with health journey)
- Trial Matches per User: 2.5+ (validates relevance of matching algorithm)
- Click-through to Coordinator: 15%+ (measures intent to participate)
Recommended Next Steps
- Week 1-3: Conduct 30 patient interviews with cancer/rare disease communities
- Week 4: Build landing page with trial matching demo (target 1,000 signups)
- Week 5-8: Develop MVP with core matching + plain language features
- Week 9-12: Clinical validation of AI accuracy with 3 medical advisors
- Week 13-16: Private beta with 100 patients from partner advocacy groups
- Week 17-20: Secure pilot agreement with 1 hospital system
- Week 21: Apply to health tech accelerator programs